Added to YB: 2026-10-14
Pitch date: 2026-10-12
IDXX [neutral]
IDEXX Laboratories, Inc.
+4.08%
current return
Author Info
The Inflection Economy shares high conviction ideas at the structural break. Sign up for the newsletter.
Company Info
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Market Cap
$41.3B
Pitch Price
$525.73
Price Target
N/A
Dividend
N/A
EV/EBITDA
25.37
P/E
36.84
EV/Sales
9.26
Sector
Health Care Equipment and Supplies
Category
growth
After the Compounder Trap: Four Stocks We’re Interested In - IDEXX Laboratories, Inc.
IDXX (monitor): IDEXX links instruments, consumables, reference labs and veterinary workflows; installed analyzers can create years of repeat business, and greater diagnostic use can expand sales without a new customer each time. Q2 organic revenue grew 9%, recurring companion-animal diagnostics revenue rose 10% organically and reported EPS increased 18%. Yet at ~$518, shares trade at ~35x the midpoint of $14.69-$14.94 2026 EPS guidance; 12% annual EPS growth over ten years and a derating to 28x yields only ~9.5% annual price returns before dividends, below the desired mid-teens.
Read full article (1 min)